English | 简体中文 | 繁體中文 | 한국어 | 日本語
Monday, 28 June 2021, 14:00 HKT/SGT
Share:
    

Source: Avance Clinical
Avance Clinical Appoints Asia Biotech Specialist to Support APAC Growth

ADELAIDE, AUS, June 28, 2021 - (ACN Newswire) - Avance Clinical, the leading Australian CRO for international biotechs and Frost & Sullivan Asia-Pacific CRO Market Leadership Award recipient, announced the appointment of Andy Hu as Business Development Manager APAC, to support increasing biotech clinical trial demand from the region.

Andy Hu

Formerly with Informa Pharma Intelligence, the international biopharma data company, Andy will head up the APAC business development program for Avance Clinical.

Andy says the main drivers for Asian biotechs looking to Australia are speed, data quality and access to international regulatory authorities.

"They select Avance Clinical in Australia because its CRO data is accepted by the FDA, and it gives them a rapid pathway for international licensing, investment and ultimately drug approvals," he said.

"I wanted to work with Avance Clinical because it's a mid-sized CRO that offers deep therapeutic experience, expedited timelines, and exceptional support to APAC biotech clients."

Avance Clinical has grown significantly over the past two years with an increasing number of clients coming from APAC to conduct their trials in Australia.

Chief Strategy Officer Ben Edwards said the appointment of Andy Hu will further support growth and strengthen relationships with clients in the region.

"Andy is multilingual, being fluent in English, Mandarin and Korean, and has completed both a Bachelor of Korean Language and Culture as well as a Master of Translation and Interpreting. He will be responsible for developing business across the APAC region to better serve our clients operating in the region," he said.

The Avance Clinical team is attending BIO Digital 2021 virtually and is available on the BIO One-on-One Partnering(TM) platform to discuss the benefits of conducting trials in Australia.

Avance Clinical has recently won the BDO Excellence in Business Award 2021 for rapid managed growth and attracting and nurturing experienced staff in a competitive global environment.

The mid-sized CRO has a reputation for going beyond the industry time and support for Sponsors, and for providing staff the training and resources needed to deliver excellence in clinical research management.

About Avance Clinical

Avance Clinical is the largest specialist Australian CRO delivering quality clinical trials in Australia and New Zealand for international biotechs. Avance Clinical has been delivering CRO services in the region for the past 24 years. Our clients are international biotechs in their early phases of drug development that need fast, agile, and adaptive solution-oriented clinical research services. Avance Clinical delivers customised solutions designed around specific client needs rather than a one size fits all approach. As a company we have focussed on state-of-the-art technology and systems across all functional areas to provide our clients with the most effective processes. Medidata, Oracle, and Medrio are just some of our technology partners. The collective pool of knowledge and experience at Avance Clinical continually grows through the careful selection of candidates who demonstrate passion and expertise in their chosen field. Visit http://www.avancecro.com for more information.

Recent Awards:
Excellence in Business Award 2021
Frost & Sullivan Asia-Pacific CRO Market Leadership Award 2020

Media Contact:
media@avancecro.com

Topic: Press release summary
Source: Avance Clinical

Sectors: BioTech, Healthcare & Pharm, Clinical Trials
https://www.acnnewswire.com
From the Asia Corporate News Network


Copyright © 2021 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.

 

Avance Clinical Releated News
Aug 12, 2021 16:30 HKT/SGT
아방스 클리니컬, 고객 가치 리더십 부문에서 프로스트&설리번 2021 아시아-태평양 CRO 최고기업상 수상
Aug 11, 2021 07:00 HKT/SGT
Avance Clinical 荣获 Frost & Sullivan 2021 年亚太地区 CRO 最佳实践奖,以表彰其客户价值领导力
Aug 11, 2021 07:00 HKT/SGT
Avance Clinical 榮獲 Frost & Sullivan 2021 年亞太地區 CRO 最佳實踐獎,以表彰其客戶價值領導力
Aug 10, 2021 14:00 HKT/SGT
Avance Clinical Awarded Frost & Sullivan 2021 Asia-Pacific CRO Best Practices Award for Customer Value Leadership
July 9, 2021 20:00 HKT/SGT
Avance Clinical Congratulates Client Tetherex Pharmaceuticals on Initiation of Dosing in a Phase 1 Clinical Study Using a Novel Single-Cycle Adenovirus Vaccine Strategy in Australia
More news >>
Copyright © 2021 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Cookies Policy | Privacy Policy | Disclaimer | Terms of Use | RSS
US: +1 214 890 4418 | Beijing: +86 400 879 3881 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575